ASTELLAS PHARMA (ALPMF) Financials
ALPMF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 23.9 billion | 13.2 billion |
| 2023-09-30 | 23.7 billion | 12.7 billion |
| 2023-06-30 | 19.4 billion | 8.4 billion |
| 2023-03-31 | 18.5 billion | 7.1 billion |
ALPMF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 256.3 million | ? |
| 2023-09-30 | 39.8 million | ? |
| 2023-06-30 | -28.8 million | ? |
| 2023-03-31 | 658.6 million | ? |
ALPMF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 152.1 million |
| 2023-09-30 | 35.7 million |
| 2023-06-30 | 324.1 million |
| 2023-03-31 | -360.5 million |
ALPMF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 2.0 billion | - | - |
| 2023-09-30 | 2.4 billion | - | - |
| 2023-06-30 | 4.2 billion | - | - |
| 2023-03-31 | 3.0 billion | - | - |
ALPMF Shares Outstanding
ALPMF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 108.3 million | 527.5 million | 1.4 billion | - |
| 2023-09-30 | 207.1 million | 517.9 million | 1.2 billion | - |
| 2023-06-30 | 113.2 million | 446.9 million | 1.2 billion | - |
| 2023-03-31 | 211.7 million | 527.6 million | 1.2 billion | - |
ALPMF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 3.0 billion | 538.2 million |
| 2023-09-30 | 2.6 billion | 498.1 million |
| 2023-06-30 | 2.6 billion | 477.0 million |
| 2023-03-31 | 2.7 billion | 468.9 million |
ALPMF
Price: $9.67
Dividend Yield: 6.86%
Forward Dividend Yield: 10.80%
Payout Ratio: 5222.00%
Dividend Per Share: 1.04 USD
Earnings Per Share: 0.02 USD
P/E Ratio: 563.55
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 18.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 21
DGR3: 5.49%
DGR5: 30.00%
DGR10: 30.00%